Quetiapine Extended Release Depression Symptoms

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
SchizophreniaDepression
Interventions
DRUG

Quetiapine Extended Release

Uptitrated starting from 300 mg in the evening on day 0, then increasing to 600 mg and up to 800 mg in the following two evenings. Previous antipsychotic was taken at the full dose on day 0, half dose on day 1 and stopped from day 2. From day 3 onwards it was possible to adjust the Seroquel XR dose, depending on the clinical response and tolerability of the patient, within the range of 400-800 mg per day

DRUG

Risperidone

Uptitrated starting from 1 mg bid (morning and evening) on day 0, then increasing to 2 mg bid and up to 3 mg in the following two days. As per the other arm, previous antipsychotic was taken at the full dose on day 0, half dose on day 1 and stopped from day 2. From day 2 onwards, it was allowed to adjust he dose of Risperidone depending on the clinical response and tolerability of the patient.

Trial Locations (21)

Unknown

Research Site, Fermo

Research Site, Bergamo

Research Site, Brindisi

Research Site, Carbonia

Research Site, Termoli

Research Site, Aversa

Research Site, Catania

Research Site, Nicosia

Research Site, Lido di Camaiore

Research Site, Messina

Research Site, Milazzo

Research Site, Monza

Research Site, Roma

Research Site, Nocera Inferiore

Research Site, Vallo della Lucania

Research Site, La Spezia

Research Site, Collegno

Research Site, Frattaminore

Research Site, Lecco

Research Site, Palermo

Research Site, Partinico

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY